Reuters logo
2 years ago
BRIEF-Moberg Pharma and Colep enters agreement for late-stage development of MOB-015
November 3, 2015 / 7:37 AM / 2 years ago

BRIEF-Moberg Pharma and Colep enters agreement for late-stage development of MOB-015

Nov 3 (Reuters) - Moberg Pharma AB

* Moberg Pharma and Colep enters development agreement for late-stage development of MOB-015

* Moberg will own all data and documentation generated from the pharmaceutical development program and plans to initiate a clinical phase 3 program in 2016.

* The parties will enter a supply agreement for a subsequent commercial phase building on synergies from other products that Colep currently manufactures for Moberg Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below